Julia Kreß

436 total citations
16 papers, 319 citations indexed

About

Julia Kreß is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Julia Kreß has authored 16 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in Julia Kreß's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and HIV Research and Treatment (5 papers). Julia Kreß is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and HIV Research and Treatment (5 papers). Julia Kreß collaborates with scholars based in Germany, Switzerland and Austria. Julia Kreß's co-authors include Michael Chudy, C. Micha Nübling, M. Heiden, Markus B. Funk, Rainer Seitz, Lutz Pichl, Brigitte Keller‐Stanislawski, Jonas Schmidt‐Chanasit, Dániel Cadar and Susanne Müller and has published in prestigious journals such as Applied and Environmental Microbiology, Journal of Medical Virology and Transfusion.

In The Last Decade

Julia Kreß

15 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia Kreß Germany	8	172	123	88	78	74	16	319
Jaye P. Brodsky United States	10	186 1.1×	170 1.4×	136 1.5×	131 1.7×	27 0.4×	16	407
Rebecca L. Townsend United States	12	171 1.0×	279 2.3×	332 3.8×	22 0.3×	6 0.1×	24	546
AM Couroucé France	11	115 0.7×	452 3.7×	8 0.1×	400 5.1×	65 0.9×	30	589
J. Wages United States	8	143 0.8×	600 4.9×	83 0.9×	518 6.6×	37 0.5×	8	738
Sigrid Nick Germany	14	151 0.9×	445 3.6×	6 0.1×	297 3.8×	236 3.2×	33	645
Bruce J. Dille United States	9	126 0.7×	296 2.4×	109 1.2×	211 2.7×	28 0.4×	13	465
Hideo Naito Japan	8	70 0.4×	434 3.5×	14 0.2×	410 5.3×	29 0.4×	9	490
C. D. L. Lycett United Kingdom	9	312 1.8×	172 1.4×	4 0.0×	125 1.6×	33 0.4×	16	498
Domenico Di Carlo Italy	12	128 0.7×	134 1.1×	16 0.2×	60 0.8×	108 1.5×	30	309
Omar J. BenMarzouk‐Hidalgo Spain	13	145 0.8×	163 1.3×	138 1.6×	39 0.5×	110 1.5×	24	484

Countries citing papers authored by Julia Kreß

Since Specialization

Citations

This map shows the geographic impact of Julia Kreß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Kreß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Kreß more than expected).

Fields of papers citing papers by Julia Kreß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Kreß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Kreß. The network helps show where Julia Kreß may publish in the future.

Co-authorship network of co-authors of Julia Kreß

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Kreß. A scholar is included among the top collaborators of Julia Kreß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Kreß. Julia Kreß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Heitmann, Anna, Markus B. Funk, Jonas Schmidt‐Chanasit, et al.. (2025). Assessment of the effectiveness of West Nile virus screening by analysing suspected positive donations among blood donors, Germany, 2020 to 2023. Eurosurveillance. 30(8). 3 indexed citations

Scheiblauer, Heinrich, et al.. (2022). Sicherheit von Blut und Blutprodukten: Testmethoden zum Nachweis der Hepatitisviren B, C und E. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 65(2). 209–219. 1 indexed citations

Himmelsbach, Kiyoshi, Susanne Mueller, Julia Kreß, et al.. (2022). Second hepatitis C virus transmission by blood components since introduction of mandatoryNATscreening in Germany. Transfusion. 63(2). 339–347. 5 indexed citations

Roth, Hanna, Julia Kreß, Michael Chudy, et al.. (2021). Genome Sequences of West Nile Virus Reference Materials. Microbiology Resource Announcements. 10(43). e0074021–e0074021. 1 indexed citations

Scheiblauer, Heinrich, M. Heiden, Markus B. Funk, et al.. (2020). Detection of hepatitis B virus infection in German blood donors 2008–2015. Vox Sanguinis. 115(3). 152–161. 4 indexed citations

Cadar, Dániel, Susanne Müller, Julia Kreß, et al.. (2017). Blood donor screening for West Nile virus (WNV) revealed acute Usutu virus (USUV) infection, Germany, September 2016. Eurosurveillance. 22(14). 78 indexed citations

Nübling, C. Micha, Sally A. Baylis, Kay-Martin Hanschmann, et al.. (2015). World Health Organization International Standard To Harmonize Assays for Detection of Mycoplasma DNA. Applied and Environmental Microbiology. 81(17). 5694–5702. 27 indexed citations

Chudy, Michael, et al.. (2013). Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany. Transfusion Medicine and Hemotherapy. 41(1). 45–51. 15 indexed citations

Müller, Benjamin, et al.. (2013). How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing. Transfusion. 53(10pt2). 2422–2430. 22 indexed citations

10.

Chudy, Michael, Marijke Weber‐Schehl, Lutz Pichl, et al.. (2011). Blood screening nucleic acid amplification tests for human immunodeficiency virus Type 1 may require two different amplification targets. Transfusion. 52(2). 431–439. 34 indexed citations

11.

Nübling, C. Micha, M. Heiden, Michael Chudy, et al.. (2009). Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions. Transfusion. 49(9). 1850–1858. 53 indexed citations

12.

Schmidt, Michael, Klaus Korn, C. Micha Nübling, et al.. (2009). First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 49(9). 1836–1844. 53 indexed citations

13.

Chudy, Michael, Kay-Martin Hanschmann, Julia Kreß, Wolfram H. Gerlich, & C. Micha Nübling. (2009). Collaborative Study to Establish a World Health Organization International Genotype Panel for Hepatitis B Virus Nucleic Acid Amplification Technique (NAT) - Based Assays. 6 indexed citations

14.

Chudy, Michael, et al.. (2008). Consistency of quantitation of HCV genotype 4 from egypt across three HCV‐RNA amplification assays. Journal of Medical Virology. 80(12). 2086–2091. 3 indexed citations

15.

Etscheid, Michael, Julia Kreß, Rainer Seitz, & Johannes Dodt. (2007). The hyaluronic acid-binding protease: A novel vascular and inflammatory mediator?. International Immunopharmacology. 8(2). 166–170. 13 indexed citations

16.

Kreß, Julia. (2004). Zelluläre Funktionen der Hyaluronsäure-bindenden Protease (HABP) : Aufklärung intrazellulärer Signalwege in humanen Endothelzellen. Publikationsserver (Universitat Marburg). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact